Combination of BET and FGFR inhibition as a rational therapeutic strategy for invasive lobular breast cancer

被引：0
|
作者：
O'Connor, Darran P. [1 ]
Walsh, Louise [1 ]
Haley, Kathryn [1 ]
Moran, Bruce
Mooney, Brian [1 ,2 ]
Madden, Stephen [1 ]
Das, Sudipto [1 ]
Rueda, Oscar [3 ]
Dowling, Catriona [1 ]
Vareslija, Damir [1 ]
Chin, Suet-Feung [3 ]
Linn, Sabine [4 ]
Young, Leonie [1 ]
Jirstrom, Karin [5 ]
Crown, John P. [6 ]
Bernards, Rene [4 ]
Caldas, Carlos
Gallagher, William M. [2 ]
Chonghaile, Triona Ni [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Dublin, Ireland
[2] Univ Coll Dublin, Dublin, Ireland
[3] Univ Cambridge, Cambridge, England
[4] Netherlands Canc Inst, Amsterdam, Netherlands
[5] Lund Univ, Malmo, Sweden
[6] St Vincents Univ Hosp, Dublin, Ireland
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-10-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-10-06
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Breast cancer index and prognostic performance in invasive lobular breast cancer
    Sella, Tal
    Nunes, Raquel
    Treuner, Kai
    Atkinson, Jennifer
    Wong, Jenna
    Zhang, Yi
    Exman, Pedro
    Dabbs, David
    Richardson, Andrea
    Schnabel, Catherine
    Sgroi, Dennis
    Oesterreich, Steffi
    Cimino-Mathews, Ashley
    Metzger, Otto
    CANCER RESEARCH, 2020, 80 (04)
  • [32] Preoperative breast MRI in patients with invasive lobular breast cancer
    Schelfout, K
    Van Goethem, M
    Kersschot, E
    Verslegers, I
    Biltjes, I
    Leyman, P
    Colpaert, C
    Thienpont, L
    Van den Haute, J
    Gillardin, JP
    Tjalma, W
    Buytaert, P
    De Schepper, A
    EUROPEAN RADIOLOGY, 2004, 14 (07) : 1209 - 1216
  • [33] Preoperative breast MRI in patients with invasive lobular breast cancer
    K. Schelfout
    M. Van Goethem
    E. Kersschot
    I. Verslegers
    I. Biltjes
    P. Leyman
    C. Colpaert
    L. Thienpont
    J. Van den Haute
    J. P. Gillardin
    W. Tjalma
    Ph. Buytaert
    A. De Schepper
    European Radiology, 2004, 14 : 1209 - 1216
  • [34] Specific Histological Subgroups in Invasive Lobular Carcinoma Might Affect Management Strategy in Invasive Lobular Carcinoma of the Breast
    Altundag, Kadri
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 779 - 779
  • [35] Specific Histological Subgroups in Invasive Lobular Carcinoma Might Affect Management Strategy in Invasive Lobular Carcinoma of the Breast
    Kadri Altundag
    Annals of Surgical Oncology, 2021, 28 : 779 - 779
  • [36] Rac1 inhibition as a therapeutic strategy in breast cancer
    Senderoff, Dana
    Azzi, Georges
    Goka, Erik
    Lippman, Marc
    CANCER RESEARCH, 2016, 76
  • [37] Combination therapeutic strategy with type I PRMT inhibition in cancer treatment
    Shi, Hui
    Fu, Xingnian
    Liu, Yilin
    Ouyang, Qiugeng
    Wang, Meng
    Huang, Jiaxin
    Wang, Long
    Wang, Youzhen
    Mi, Yuan
    Wu, Haiping
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Another Breast Cancer Entity Confirmed: Genomics of Invasive Lobular Breast Cancer
    Gatza, Michael L.
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (16) : 1838 - +
  • [39] Invasive Lobular Breast Cancer: Does Grade Matter?
    Margenthaler, Julie A.
    JOURNAL OF SURGICAL RESEARCH, 2011, 169 (01) : 16 - 18
  • [40] Invasive lobular carcinoma predicts micrometastasis in breast cancer
    Gainer, Sarah M.
    Lodhi, Ashutosh K.
    Bhattacharyya, Anirban
    Krishnamurthy, Savitri
    Kuerer, Henry M.
    Lucci, Anthony
    JOURNAL OF SURGICAL RESEARCH, 2012, 177 (01) : 93 - 96
12345